Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penpulimab + SOX in Perioperative Gastric Cancer
NCT05519202Phase 2Unknown
- Sponsor
- Lishui City Central Hospital
- Start
- Aug 2022
- Primary completion
- Aug 2023
- Modality
- Immune Checkpoint Inhibitors
01
Overview
A Phase 2 trial of penpulimab in gastric cancer (GC), sponsored by Lishui City Central Hospital. Status: unknown.
02
Drugs
penpulimab
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT05519202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05519202.